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A R T I C L E   I N F O S U M M A R Y 
A library of dienones were synthesized as candidate antifungal agents. These 
compounds were screened against Saccharomyces cerevisiae and Candida albicans 
using macro-broth susceptibility assay. The dienones exhibited a broad range of 
inhibition against S. cerevisiae (0.2-99%) and C. albicans (0-99%). 3,5-bis(p- 
trifluoromethylbenzylidene)-1-methyl-piperidine-4-one was identified as the 
most potent inhibitor of S. cerevisiae. Whereas, the most promising inhibitor of C. 
albicans was 2,6-bis(pyridine-3ylmethylene)cyclohexan-1-one. 
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INTRODUCTION 
Fungal infections now contribute more significantly to 
microbe-related morbidity and mortality due to 
limited number of available antifungals. (Shreaz, et al 
2013). In recent years only echinocandins have been 
introduced as a new class of antifungals. Drug 
resistance, adverse side effects and limited modes of 
drug delivery has led to an increased interest in 
identifying novel drug targets within the mycota. The 
fungal plasma membrane (PM) H+-ATPase is a vital 
enzyme for the growth of fungi and it maintains an 
electrochemical proton gradient required for the 
uptake of nutrients (Manavathu, et al 1999). The PM 
H+-ATPase has been shown to be inhibited by 
sulphinimides (eg.  omeprazole) (Monk, et al 1995), 
ebselen    and    α,β-unsaturated    carbonyls  such   as 
curcumin (Neelofar, et   al   2011).   These   findings 
prompted us to synthesize a dienone library similar to 
curcumin and to investigate their antifungal activities. 
MATERIALS AND METHODS 
Using the Claisen-Schmidt condensation a dienone 
library was synthesized between N-methyl- 
piperidin-4-one/cycloalkanones with various 
substituted aldehydes. These compounds were 
characterized by LCMS, IR, 1H and 13C NMR and 
screened   for   their   antifungal   activity   against S. 
cerevisiae and C. albicans using a macro-broth dilution 
susceptibility assay. Test compounds and controls 
were incubated at 32°C, 100 rpm. Optical density was 
measured at 600nm after 24 hours of incubation.    
RESULTS AND DISCUSSION 
The inhibitory activity of the dienones were analysed 
from the dose response curves. EC50, area under the 
curve (AUC), symmetry of the curve & slope values 
were obtained from the dose response curves fitted to 
4 and 5 parameter equations. Representative dose- 
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response curves of the most potent compounds with 
S. cerevisiae as a target cell (Fig. 1). 
 
Fig. 1. Representative dose response curves of the most 
potent compounds against S. cerevisiae. 
The pyridyl derivatives of N-methyl-piperidone, 
cyclopentanone   and   cyclohexanone   showed good 
inhibitory activity against S. cerevisiae with EC50 
ranged from 5.5 – 20.3 µM. In addition, the 
benzylidene derivatives of N-methyl-piperidones 
depicted a wide range of inhibition against S. 
cerevisiae with EC50 ranged from 0.6 – 337 µM, 
depending on the positioning of electron 
withdrawing or electron donating groups present on 
the benzene ring. The pyridyl derivatives of 
cyclopentanone and cyclohexanone were effective 
inhibitors of C. albicans. However, the thienylidene 
derivatives were not effective inhibitors of either S. 
cerevisiae or C. albicans. 
The table 1 below reveals the inhibitory activity of the 
most potent compounds against S. cerevisiae and C. 
albicans. Miconazole was employed as positive control 
in all tests.
 
Table 1. In vitro antifungal testing results of the dienones against S. cerevisiae and C. albicans. 
 
Most potent compounds 
S. Cerevisiae EC50 (µM) 
Mean ± SD, n=6 
C. albicans EC50 (µM) 
Mean ± SD, n=4 
3,5-bis((E)-3-trifluoromethylbenzylidene)-1-methylpiperidin-4-one 1.53 ± 0.73 525.00 ± 33.94 
3,5-bis((E)-4-trifluoromethylbenzylidene)-1-methylpiperidin-4-one 0.62 ± 0.26a 473.50 ± 7.78 
3,5-bis((E)-3-trifluoromethyoxybenzylidene)-1-methylpiperidin-4-one 2.83 ± 0.96 548.50 ± 115.26 
3,5-bis((E)-3-chlorobenzylidene)-1-methylpiperidin-4-one 1.21 ± 1.29 95.82 ± 15.82 
3,5-bis((E)-3-nitrobenzylidene)-1-methylpiperidin-4-one 1.87 ± 0.60 666.00 ± 70.71 
2,6-bis(pyridin-3-ylmethylene) cyclohexan-1-one 5.57 ± 2.47 57.57 ± 5.78 
2,6-bis(pyridin-4-ylmethylene) cyclohexan-1-one 6.25 ± 1.49 50.66 ± 3.50b 
2,5-bis(pyridin-4-ylmethylene) cyclopentan-1-one 8.46 ± 0.68 68.48 ± 3.27 
Miconazole 0.12 ± 0.01 0.04 ± 0.02 
a most potent against S. cerevisiae, b most potent against C. albicans. 
CONCLUSIONS 
3,5-bis((E)-(4-trifluoromethyl-benzylidene)-1-methyl- 
piperidin-4-one was the most potent inhibitor of S. 
cerevisiae (EC50 = 0.62 µM), whereas 2,6-bis-[(E)-(4- 
pyridyl)methylidene] cyclohexanone showed the 
highest inhibitory activity against C. albicans (EC50 = 
50 µM). Although not as effective as the control azole 
antifungal. These results offer an encouraging 
framework that could lead to the discovery of novel 
antifungal agents. 
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